Remdesivir may be approved in Japan on Thursday - health minister
Published
Gilead Sciences Inc's antiviral drug remdesivir may be approved in Japan for domestic COVID-19 patients when the health ministry's review board is held on Thursday, Japanese Health Minister Katsunobu Kato said.
Full Article